10.1016/S0022-5223(99)70389-2
10.1177/000456329703400510
10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D
10.1016/S0006-8993(99)02438-5
10.1096/fasebj.13.12.1611
10.1016/S0003-4975(01)02399-2
10.1097/00006123-200106000-00012
10.1016/S1010-7940(99)00136-0
10.1016/S1010-7940(96)80358-7
10.1161/01.STR.22.10.1254
10.1016/0006-8993(95)00051-Q
Barger SW, 1992, S100β stimulates calcium fluxes in glial and neuronal cells, J Biol Chem, 267, 9689, 10.1016/S0021-9258(19)50145-4
10.1016/0006-8993(95)00160-R
Baudier J, 1988, Interactions between the microtubule‐associated proteins and S100b regulate phosphorylation by the Ca 2+ calmodulin‐dependent protein kinase II, J Biol Chem, 263, 5876, 10.1016/S0021-9258(18)60647-7
Baudier J, 1992, Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b‐binding protein, Biochemistry, 89, 11627
Beaudeux JL, 1999, La protéine S‐100β: un nouveau marquer biologique de pathologie cérébrale, Ann Biol Clin, 57, 261
Bianchi R, 1993, S‐100 protein, but not calmodulin, binds to the glial fibrillary acidic protein and inhibits its polymerization in a Ca2+‐dependent manner, J Biol Chem, 268, 12669, 10.1016/S0021-9258(18)31440-6
10.1016/0167-4889(94)90095-7
10.1016/0167-4889(96)00098-5
Biberthaler P, 2000, Influence of alcohol exposure on S‐100b serum levels, Acta Neurochir, 76, 177
10.1097/00024382-200116020-00002
10.1016/S1053-0770(97)90160-9
10.1161/01.CIR.103.22.2694
10.1111/j.1471-4159.1992.tb09743.x
10.1016/S0006-8993(01)02519-7
10.1161/01.STR.28.10.1961
10.1016/S0736-5748(99)00083-0
10.1016/S0925-4927(99)00033-5
10.1097/00000539-200011000-00005
10.1016/0143-4160(85)90004-1
Donato R, 1988, Calcium‐independent, pH‐regulated effects of S‐100 proteins on assembly‐disassembly of brain microtubule protein in vitro, J Biol Chem, 263, 106, 10.1016/S0021-9258(19)57363-X
10.1016/0143-4160(91)90040-L
10.1016/S1357-2725(01)00046-2
10.1111/j.1468-1331.1999.tb00010.x
10.3109/10673229709000299
10.1016/S0022-510X(00)00442-1
10.1016/S0165-3806(01)00172-9
Fagnart OC, 1988, Particle counting immunoassay of S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system, Clin Chem, 34, 1387, 10.1093/clinchem/34.7.1387
10.1016/S0022-510X(96)05351-8
Friend WC, 1992, Cell‐specific expression of high levels in human S100β in transgenic mouse brain is dependent of gene dosage, J Neurosci, 12, 4337, 10.1523/JNEUROSCI.12-11-04337.1992
Fujii T, 1994, Calcium‐dependent regulation of smooth muscle calponin by S100, J Biochem, 116, 121, 10.1093/oxfordjournals.jbchem.a124484
10.1111/j.1469-445X.2000.01974.x
10.1046/j.1365-2044.2000.01466.x
10.1096/fasebj.10.2.8641565
10.1016/S0920-9964(99)00146-2
Gazzolo D, 1998, S100 blood concentrations in children subjected to cardiopulmonary bypass, Clin Chem, 44, 1058, 10.1093/clinchem/44.5.1058
10.1093/clinchem/47.10.1836
10.1016/0166-4328(93)90157-L
Gerlai R, 1995, Abnormal exploratory behavior in transgenic mice carrying multiple copies of the human gene for S100β, J Psychiatr Neurosci, 20, 105
10.1016/0166-4328(93)90006-C
10.1037/0735-7044.108.1.100
Goncalves DS, 2000, Extracellular S100B protein modulates ERK in astrocyte cultures, Glial Cells, 11, 807
10.1016/S0304-3940(97)00701-5
10.1016/S0197-4580(97)00167-X
10.1016/S0197-4580(98)00074-8
Grocott HP, 2001, Serum S100 protein as a marker of cerebral damage during cardiac surgery, Br J Anaesth, 86, 289
10.1016/S0003-4975(98)00276-8
Hagiwara M, 1988, Modulation of tyrosine phosphorylation of p36 and other substrates by the S‐100 protein, J Biol Chem, 263, 6438, 10.1016/S0021-9258(18)68805-2
Haimoto H, 1987, Differential distribution of immunoreactive S100‐alpha and S100‐beta proteins in normal nonnervous human tissues, Lab Invest, 57, 489
10.3171/jns.1989.71.5.0727
10.1016/0006-8993(93)91195-X
10.1161/01.STR.31.11.2670
10.1016/S0076-6879(83)02026-1
10.1046/j.1471-4159.1997.69062294.x
10.1097/00006123-199909000-00010
10.1080/02699050050203540
10.1111/j.1432-1033.1978.tb12539.x
Jackson RG, 2001, Extra cranial sources of S100B, Br J Anaesth, 86, 601
Jankovic BD, 1980, Schizophrenia and other psychiatric diseases: evidence for neurotissue hypersensitivity, Clin Exp Immunol., 40, 515
Jankovic BD, 1982, Delayed skin hypersensitivity reactions to human brain S‐100 protein in psychiatric patients, Biol Psychiatry, 17, 687
Jankovic BD, 1982, Hypersensitivity to human brain S‐100 protein in chronic alcoholics, Clin exp Immunol, 49, 598
10.1002/j.1460-2075.1986.tb04669.x
10.1016/S1053-0770(05)80231-9
10.1016/S0003-4975(98)00229-X
10.1016/S0003-4975(00)02612-6
10.1016/0006-8993(76)90885-4
10.1111/j.1471-4159.1990.tb01958.x
10.1016/S0969-2126(96)00111-6
10.1016/S0197-0186(01)00047-X
10.1016/S0022-5223(97)70271-X
Kuzumi E, 2000, Serum S100 protein as a marker of cerebral damage during cardiac surgery, Br J Anaesth, 85, 936
10.1111/j.1600-0404.1995.tb01696.x
10.1016/S0143-4160(96)90033-0
10.1016/S0022-3956(01)00003-6
10.1016/S0003-4975(01)02536-X
10.1016/0006-8993(86)90016-8
10.1046/j.1471-4159.1998.71041421.x
10.1046/j.1471-4159.2000.0740143.x
10.1016/0169-328X(94)90165-1
10.1016/S0022-5223(98)70128-X
10.1016/S0022-3956(01)00039-5
10.1016/0306-4522(94)90201-1
10.1016/0169-328X(95)00293-2
10.1016/0197-4580(92)90002-F
10.1161/01.STR.29.11.2363
10.1016/S0969-2126(98)00024-0
10.1016/S0006-8993(97)00297-7
10.1016/S0006-8993(98)01014-2
10.1001/archpsyc.57.7.637
McKeating EG, 1998, Relationship of neuron specife enolase and protein S‐100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury, Acta Neurochir, 71, 117
10.1016/0165-5728(94)00180-V
10.1016/S0031-9384(00)00299-7
10.1016/0304-3940(79)90122-8
10.1016/S0304-3940(98)01001-5
10.1161/01.STR.28.10.1956
10.1111/j.1600-0404.1997.tb00256.x
10.1111/j.1600-0404.1994.tb01628.x
10.1016/0006-291X(65)90320-7
10.3109/13550289709029465
10.1016/S0197-4580(01)00293-7
10.1097/00005072-199603000-00002
Mussack T, 2000, S‐100b as a screening marker of the severity of minor head trauma (MHT): a pilot study, Acta Neurochir, 76, 393
10.1002/(SICI)1098-2396(199605)23:1<1::AID-SYN1>3.0.CO;2-E
10.1016/S0169-328X(97)00221-0
10.1016/S0304-3940(97)00947-6
10.1016/S0925-4927(98)00042-0
10.1016/S1386-6532(01)00196-2
10.1016/0169-328X(95)00145-I
10.1016/S0197-0186(01)00048-1
10.1016/S0006-8993(99)02251-9
10.1089/089771501300227297
10.1016/S0014-5793(98)00014-3
Portela LV, 2002, Serum S100B levels in patients with lupus erythematosus. Preliminary observation, Clin Diagn Lab Immunol, 9, 164
10.1097/00006123-199909000-00012
10.1016/S0306-4522(99)00074-3
10.1034/j.1399-6576.1999.430502.x
10.1016/S1053-0770(00)90012-0
10.1016/S0009-8981(01)00573-3
10.1016/0888-7543(95)80079-2
10.1097/00000539-200110000-00008
10.1016/0031-9384(95)02247-3
10.1016/S0031-9384(96)80038-2
10.1016/S0300-9572(00)00348-8
10.1097/00005373-199810000-00025
Rothoerl RD, 2000, S‐100 Serum levels and outcome after severe head injury, Acta Neurochir, 76, 97
10.1016/S0165-0327(00)00321-9
10.1046/j.1365-2990.1999.00196.x
10.1016/0968-0004(96)10020-7
10.1016/0197-4580(96)00104-2
10.1097/00005072-199703000-00007
10.1046/j.1471-4159.2000.0740295.x
10.1016/0169-328X(94)90378-6
10.1016/0014-5793(89)81577-7
10.1016/S0167-4889(98)00134-7
10.1097/00005072-199405000-00003
10.1016/S0003-4975(96)01229-5
10.3171/jns.1985.63.3.0417
Tei I, 1999, Clinical study of serum S‐100 beta protein as marker of brain injury in cardiovascular surgery, Kyobu Geka, 52, 1090
10.1016/0006-8993(94)91549-0
10.1016/0006-8993(94)91550-4
10.1016/0169-328X(94)00269-K
10.1016/0022-510X(94)90215-1
10.1016/0167-4889(94)90101-5
10.1016/0006-8993(91)91579-P
10.1016/S0169-328X(99)00145-X
10.1016/0003-4975(95)00904-3
10.1016/0006-8993(90)90210-3
10.1016/0893-133X(94)00081-A
10.1016/S0006-8993(97)01002-0
10.1016/S0006-3223(98)00217-0
10.1016/S0006-8993(97)01284-5
10.1097/00005373-199912000-00026
10.1016/0006-8993(95)00991-7
10.1016/S0165-1781(00)00202-X
Zimmer DB, 1986, Identification of a molecular target for the calcium‐modulated protein S100. Fructose‐1,6‐bisphosphate aldolase, J Biol Chem, 261, 11428, 10.1016/S0021-9258(18)67402-2
10.1152/ajpcell.1987.252.3.C285
10.1016/0361-9230(95)00040-2
